Relationship Between BIM Gene Polymorphism and Therapeutic Efficacy in the 
Retreatment of Advanced Non-small Cell Lung Cancer with Tyrosine Kinase Inhibitor

Relationship Between BIM Gene Polymorphism and Therapeutic Efficacy in the 
Retreatment of Advanced Non-small Cell Lung Cancer with Tyrosine Kinase Inhibitor

Background and objective BIM gene is a member of the BCL-2 family, is involved in cell death. The aim of this study is to explore the relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitor (EGF...

Full description

Bibliographic Details
Main Authors: Lei ZHENG, Baochai LIN, Zhengbo SONG, Fangjun XIE, Wei HONG, Jianguo FENG, Lan SHAO, Yingping ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-12-01
Series:Chinese Journal of Lung Cancer
Subjects:
BIM Gene
Polymorphism
Lung neoplasms
Tyrosine Kinase Inhibitor
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.12.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.12.03

Similar Items